Sanofi-aventis group,   France

angiotensin II receptor antagonist

Film-coated tablets, 150 mg and 300 mg.

Non-steroidal anti-inflammatory drug
Solution for topical application 0,15%.

Non-steroidal anti-inflammatory drug
Spray for topical use dosed with 0.27 mg / dose.

A hypoglycemic agent, a glucagon-like receptor polypeptide, an agonist

The solution for subcutaneous administration was 0.05 mg / ml (10 μg / dose) and 0.1 mg / ml (20 μg / dose).

A fully humanized monoclonal antibody (IgG1). Protein convertase inhibitor subtilisin-kexin type 9 (PCSK9)

A solution for subcutaneous administration is 75 mg / ml and 150 mg / ml.